Just stay out of our way boomer.
No NDA for ILD so you better start looking for a new job ASAP
No pediatric indication for you. You’ll be gone soon enough.
There are actually some good people in ILD. There have just been market factors that have consequences. Losing a branded competitor decreases noise about lung disease. Generic competition didn’t help. And ultimately Al leaving has negative impact on the team culture. OFEV was never meant to be a $2+ billion drug. The brand got lucky and now expectations are high and unreasonable.Entire ILD division is a complete flop!! Incompetent nincompoops!